Drugmakers Prep for U.S. Rules on Disclosing Payments

Drug companies and medical-device makers would be forced to publicly disclose any money paid to doctors under new U.S. regulations designed to make patients aware of conflicts of interest that may affect their health.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.